PAWR and colonic neoplasm: In conclusion, Par-4 may play a significant role in the treatment of colon cancer by increasing the sensitivity of colon cancer cells to undergo apoptosis through the binding of Par-4 to NFκB in the cytoplasm, thus inhibiting translocation of NFκB to the nucleus and altering both DROSHA and microRNA expression.